Merck Bolsters Oncology Pipeline with $2.13 Billion SciBrunch Licensing Deal for KRAS G12D Inhibitor
In a significant move to reshape its oncology portfolio ahead of impending patent cliffs, Merck & Co. has secured exclusive...
science
Revolutionizing Biopharma: The Antibody Developability Consortium Launches to Decode Drug Success with AI
In a landmark move for the biotechnology and pharmaceutical sectors, Ginkgo Bioworks—through its data-focused arm, Ginkgo Datapoints—and the federated learning...
A New Frontier in Alzheimer’s: Blocking Immune Infiltration to Prevent Neurodegeneration
In the decades-long battle against Alzheimer’s disease and related "tauopathies," the scientific community has largely focused on clearing the toxic...
Unlocking the Genetic Mystery: AI and Fruit Flies Identify BRSK1 as a Driver of Rare Neurodevelopmental Disorders
For families navigating the often-harrowing odyssey of undiagnosed rare diseases, the "diagnostic odyssey" is frequently marked by years of medical...
Unmasking the Molecular Saboteurs: New Imaging Reveals How DNA Structure Dictates Vulnerability
In the delicate dance of cellular life, DNA is constantly under siege. From the constant barrage of environmental stressors to...
The Media Bottleneck: How Just – Evotec Biologics is Rethinking Biomanufacturing Logistics
In the high-stakes world of biopharmaceutical manufacturing, the focus is often placed on the final molecule—the complex protein therapy that...
Weekly Tech & Science Roundup: From Interstellar Radio Waves to the Future of Linux Hardware
In a rapidly evolving landscape of scientific discovery and open-source innovation, the week of September 27, 2026, has provided a...
Market Paradox: Nektar Therapeutics’ Legal Win Against Eli Lilly Fails to Ignite Investor Confidence
This past week, the biotechnology sector witnessed a rare and counterintuitive phenomenon: a significant courtroom victory that translated into a...
Evolving Downstream: JNC’s MLP Technology Addresses the ‘Big Molecule’ Bottleneck in Bioprocessing
As the biopharmaceutical landscape shifts from traditional monoclonal antibodies toward complex viral vectors, mRNA vaccines, and sophisticated cell-based therapies, the...
The Clockwork of Human Movement: How Structural Biology Unlocks the Secrets of Muscle Contraction
Every movement a human makes—from the blink of an eye to the stride of an Olympic sprinter—relies on a microscopic,...
Unlocking the Vascular Code: New Research Reveals How APOE4 Drives Alzheimer’s and Neurodegeneration
In the quest to demystify Alzheimer’s disease, science has long looked to the brain’s neurons as the primary battlefield. However,...
Decoding the Microbial Dark Matter: New CRISPR-Based Platform Revolutionizes Phage Engineering
In a significant breakthrough for synthetic biology and antimicrobial research, scientists at the University of Otago—Ōtākou Whakaihu Waka—in New Zealand...
